SCHEDULE 13G FOR ALDEYRA THERAPEUTICS, INC. BY DOMAIN PARTNERS VI, L.P.

Company

Aldeyra Therapeutics, Inc.

Filed

February 5, 2015

Accession Number

0000904454-15-000047

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →